Targeting factor replacement therapy in severe hemophilia: which level is important?
about
A close insight to factor VIII inhibitor in the congenital hemophilia A.New therapies for hemophilia.Emerging treatments for hemophilia: patients and their treaters spoilt for choice, but laboratories face a difficult path?If you know you will also see: population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia.Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia.
P2860
Targeting factor replacement therapy in severe hemophilia: which level is important?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting factor replacement therapy in severe hemophilia: which level is important?
@en
type
label
Targeting factor replacement therapy in severe hemophilia: which level is important?
@en
prefLabel
Targeting factor replacement therapy in severe hemophilia: which level is important?
@en
P356
P1476
Targeting factor replacement therapy in severe hemophilia: which level is important?
@en
P2093
Erik Berntorp
P304
P356
10.1055/S-0035-1552562
P577
2015-10-09T00:00:00Z